Effects of Resveratrol on In Vivo Ovarian Cancer Cells Implanted on the Chorioallantoic Membrane (CAM) of a Chicken Embryo Model

Kenny Chitcholtan,Melanie Singh,Alex Tino,Ashley Garrill,Peter Sykes
DOI: https://doi.org/10.3390/ijms25084374
IF: 5.6
2024-04-17
International Journal of Molecular Sciences
Abstract:Ovarian cancer poses a significant threat to patients in its advanced stages, often with limited treatment options available. In such cases, palliative management becomes the primary approach to maintaining a reasonable quality of life. Therefore, the administration of any medication that can benefit patients without a curative option holds potential. Resveratrol, a natural compound known for its in vitro anticancer activities, has generated contrasting results in vivo and human studies. In this study, we aimed to assess the anticancer effects of resveratrol on ovarian cancer cells grown on the chorioallantoic membrane (CAM) of chicken embryos. Two ovarian cancer cell lines, OVCAR-8 and SKOV-3, were cultured in collagen scaffolds for four days before being implanted on the CAM of chicken embryos on day 7. Different doses of resveratrol were applied to the CAM every two days for six days. Subsequently, CAM tissues were excised, fixed, and subjected to histological analysis. Some CAM tumours were extracted to analyse proteins through Western blotting. Our findings indicate that specific doses of resveratrol significantly reduce angiogenic activities, pNF-κB levels, and SLUG protein levels by using immunohistochemistry. These results suggest that resveratrol may have the potential to impact the behaviour of ovarian cancer CAM tumours, thereby warranting further consideration as a complementary treatment option for women with incurable ovarian cancer.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper aims to investigate the effects of resveratrol on ovarian cancer cells implanted in the chicken embryo chorioallantoic membrane (CAM) model. Specifically, the researchers evaluated the effects of different doses of resveratrol on two ovarian cancer cell lines (OVCAR-8 and SKOV-3). By culturing these cells in the CAM model and administering different doses of resveratrol, the researchers observed the following results: 1. **Reduced angiogenic activity**: Specific doses of resveratrol significantly reduced angiogenic activity in tumor tissues. 2. **Decreased pNF-κB levels**: Resveratrol was able to significantly lower pNF-κB levels, particularly at a dose of 91.24 μg (2 mM). 3. **Reduced SLUG protein levels**: Resveratrol also reduced SLUG protein levels, indicating that it may inhibit the invasive behavior of tumor cells. These findings suggest that resveratrol has potential anti-tumor effects on ovarian cancer cells in the CAM model, especially at certain specific doses. This provides a new research direction for using resveratrol as an adjuvant therapy for patients with advanced ovarian cancer.